Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Authors

Hafiz Taha Mahmood
Mona Bafadhel (ORCID: https://orcid.org/0000-0002-9993-2478)
Sanjay Ramakrishnan (ORCID: https://orcid.org/0000-0002-3003-7918)
Imran Howell (ORCID: https://orcid.org/0000-0002-6033-0488)
J. Mark Melhorn (ORCID: https://orcid.org/0000-0003-3977-7012)
Richard Russell (ORCID: https://orcid.org/0000-0002-3890-7201)
Christine Mwasuku (ORCID: https://orcid.org/0000-0001-6493-3705)
Mahdi Mahdi (ORCID: https://orcid.org/0009-0008-7946-628X)
Ian Pavord (ORCID: https://orcid.org/0000-0002-4288-5973)
Stefan Peterson (ORCID: https://orcid.org/0000-0001-7203-3096)
Karolina Krassowska
Thomas Bengtsson (ORCID: https://orcid.org/0000-0002-9667-8873)
Laura Bermejo-Sanchez

Institutions

The University of Western Australia (AU)
University of Oxford (GB)
WeMind (SE)
Oxford BioMedica (United Kingdom) (GB)
Institute for Respiratory Health (AU)

Publication Details

Journal: The Lancet Respiratory Medicine
Published: 2024-11-28
DOI: https://doi.org/10.1016/s2213-2600(24)00299-6
Citations: 86
Primary Topic: Asthma and respiratory diseases
Type: article
Field-Weighted Citation Impact: 28.08

Funders

AstraZeneca
National Institute for Health and Care Research
King's Health Partners

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Hafiz Taha Mahmood, Mona Bafadhel, Sanjay Ramakrishnan, Imran Howell et al.

Nov 28, 2024

86 citations

The Lancet Respiratory Medicine

Asthma and respiratory diseases

28.08

article

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Hafiz Taha Mahmood, Mona Bafadhel, Sanjay Ramakrishnan, Imran Howell, J. Mark Melhorn, Richard Russell, Christine Mwasuku, Mahdi Mahdi, Ian Pavord, Stefan Peterson, Karolina Krassowska, Thomas Bengtsson, Laura Bermejo-Sanchez

November 28, 2024article en

86 citations

Abstract

No abstract available for this paper.

The Lancet Respiratory MedicineVol. 13(1)

The University of Western Australia (AU), University of Oxford (GB), WeMind (SE), Oxford BioMedica (United Kingdom) (GB), Institute for Respiratory Health (AU)

AstraZeneca, National Institute for Health and Care Research, King's Health Partners

Good health and well-being

Openalex Percentile: Top 0%

Asthma and respiratory diseases

28.08

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.